Literature DB >> 16830189

Detection of IgG and IgM in sera from canines with blastomycosis using eight blastomyces dermatitidis yeast phase lysate antigens.

Christine M Sestero1, Gene M Scalarone.   

Abstract

The objective of this study was to compare the efficacy of eight Blastomyces dermatitidis yeast phase lysate antigens (T-58: dog, Tennessee; T-27: polar bear, Tennessee; ERC-2: dog, Wisconsin; B5894: human, Minnesota; SOIL: soil, Canada; B5896: human, Minnesota; 48089: human, Zaire; 48938: bat, India) in the detection of the immunoglobulins IgG and IgM in serum specimens from canines with blastomycosis. An indirect enzyme-linked immunosorbent assay (ELISA, peroxidase system) was used to analyze sera collected during four different intervals post-infection. The yeast lysate antigen 48938 was a reactive antigen for the detection of both IgG (mean absorbance value range: 1.198-2.934) and IgM (mean absorbance value range: 0.505-0.845). For the same sera, antigen T-27 was also effective in the detection of IgG (mean absorbance value range: 0.904-3.356) and antigen 48089 was useful for the detection of IgM (mean absorbance value range: 0.377-0.554). The yeast lysate antigen B5894 proved to be a poor antigen for the detection of both IgG and IgM (mean absorbance value ranges: 0.310-0.744 for IgG, 0.025-0.069 for IgM). Inherent variations in yeast lysate antigens such as these may be utilized to develop improved immunoassay procedures for the specific detection of IgG or IgM in cases of blastomycosis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16830189     DOI: 10.1007/s11046-006-0028-7

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  17 in total

1.  Serological tests for blastomycosis: assessments during a large point-source outbreak in Wisconsin.

Authors:  B S Klein; J M Vergeront; L Kaufman; R W Bradsher; U N Kumar; G Mathai; B Varkey; J P Davis
Journal:  J Infect Dis       Date:  1987-02       Impact factor: 5.226

2.  Comparison of the enzyme immunoassay, immunodiffusion, and complement fixation tests in detecting antibody in human serum to the A antigen of Blastomyces dermatitidis.

Authors:  B S Klein; J N Kuritsky; W A Chappell; L Kaufman; J Green; S F Davies; J E Williams; G A Sarosi
Journal:  Am Rev Respir Dis       Date:  1986-01

3.  Serological differences in three Blastomyces dermatitidis strains.

Authors:  R C Axtell; G M Scalarone
Journal:  Mycoses       Date:  2002-12       Impact factor: 4.377

4.  Delayed hypersensitivity responses of experimental animals to histoplasmin from the yeast and mycelial phases of Histoplasma capsulatum.

Authors:  G M Scalarone; H B Levine; S D Chaparas
Journal:  Infect Immun       Date:  1978-09       Impact factor: 3.441

5.  Serological differences in two Blastomyces dermatitidis isolates from different geographical regions of North America.

Authors:  R C Axtell; G M Scalarone
Journal:  Mycopathologia       Date:  2002       Impact factor: 2.574

6.  Detection of antibodies and delayed dermal hypersensitivity with different lots of Blastomyces dermatitidis yeast lysate antigen: stability and specificity evaluations.

Authors:  A Wakamoto; B M Fryer; M A Fisher; T J Johnson; D K Lundgren; J D Knickerbocker; S L Rounds; G M Scalarone
Journal:  Mycoses       Date:  1997-11       Impact factor: 4.377

7.  Comparative serological evaluation of 10 Blastomyces dermatitidis yeast phase lysate antigens from different sources.

Authors:  R O Abuodeh; E M Chester; G M Scalarone
Journal:  Mycoses       Date:  2004-04       Impact factor: 4.377

8.  Histoplasmin-CYL, a yeast phase reagent in skin test studies with humans.

Authors:  H B Levine; G M Scalarone; G D Campbell; J R Graybill; P C Kelly; S D Chaparas
Journal:  Am Rev Respir Dis       Date:  1979-04

9.  Western immunoblot analysis and serologic characterization of Blastomyces dermatitidis yeast form extracellular antigens.

Authors:  S F Hurst; L Kaufman
Journal:  J Clin Microbiol       Date:  1992-12       Impact factor: 5.948

Review 10.  Blastomycosis.

Authors:  R W Bradsher
Journal:  Clin Infect Dis       Date:  1992-03       Impact factor: 9.079

View more
  5 in total

1.  Isoelectric focusing and ELISA evaluation of a Blastomyces dermatitidis human isolate.

Authors:  Jack F Shurley; Gene M Scalarone
Journal:  Mycopathologia       Date:  2007-06-20       Impact factor: 2.574

2.  Blastomyces dermatitidis Antibody and Antigen Detection: Comparison of Four Lysate Antigens and Antibodies Prepared from Human Isolates from a Blastomycosis Outbreak.

Authors:  Jordan T Hammon; Bryn C Kennell; Gene M Scalarone
Journal:  Mycopathologia       Date:  2019-10-03       Impact factor: 2.574

3.  Biological function and molecular mapping of M antigen in yeast phase of Histoplasma capsulatum.

Authors:  Allan Jefferson Guimarães; Andrew John Hamilton; Herbert Leonel de M Guedes; Joshua Daniel Nosanchuk; Rosely Maria Zancopé-Oliveira
Journal:  PLoS One       Date:  2008-10-17       Impact factor: 3.240

4.  Blastomyces dermatitidis Yeast Lysate Antigen Combinations: Antibody Detection in Dogs with Blastomycosis.

Authors:  Alex R Boyd; Jamie L Vandyke; Gene M Scalarone
Journal:  Vet Med Int       Date:  2013-10-08

5.  Blastomyces dermatitidis: Antibody Detection in Sera from Dogs with Blastomycosis with Yeast Lysate Antigens Produced from Human and Dog Isolates.

Authors:  Katie Mondada; Jessie Fullmer; Eric Hungerford; Katrina Novack; Kristen Vickers; Gene Scalarone
Journal:  Vet Med Int       Date:  2014-02-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.